GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Pfizer, Inc. (PFE) [hlAlert]

Pfizer Inc is a research-based, global pharmaceutical company that discovers and develops innovative, value-added products that improve the quality of
life of people around the world and help them enjoy longer, healthier, and more productive lives. Pfizer has three business segments: health care, animal health and consumer health care. Its products are available in numerous countries. (Company Press Release).
( Total: 27 Current Stock Recommendations )
Pfizer, Inc.   (27)
Sell Hold 22% Buy 70%
Related companies
Glaxosmithkline Plc   (19)
Sell 16% Hold 63% Buy 21%
Abbott Laboratories   (29)
Sell Hold 24% Buy 69%
Eli Lilly And ...   (29)
Sell Hold 34% Buy 52%
Novartis Ag   (19)
Sell Hold 32% Buy 58%
Alcon Inc   (11)
Hold 64% Buy 36%
Bristol-myers ...   (23)
Sell Hold 30% Buy 65%
Johnson & Johnson   (33)
Sell Hold 27% Buy 70%
Merck & Company, ...   (24)
Hold 25% Buy 75%
Filter by Gains:   
  
Rating:
Hold PFE
Pfizer, Inc. (PFE) rated Neutral by Sun Trust Rbsn Humphrey
Thursday,  Nov 26, 2015  8:25 AM ET

Rating:
Hold PFE
down 13.71 %
Pfizer, Inc. (PFE) upgraded to Neutral by Sun Trust Rbsn Humphrey
Wednesday,  Nov 25, 2015  10:25 AM ET

Rating:
Buy PFE
down 4.91 %
Pfizer, Inc. (PFE) rated Buy with price target $46 by Argus
Tuesday,  Nov 3, 2015  8:25 AM ET

Rating:
Buy PFE
up 16.86 %

Rating:
Buy PFE
up 4.75 %

Rating:
Hold PFE

Rating:
Buy PFE
up 5.78 %

Rating:
Buy PFE
up 18.06 %
Pfizer, Inc. (PFE) upgraded to Outperform by Credit Suisse
Wednesday,  Oct 9, 2013  8:25 AM ET

Rating:
Hold PFE
Pfizer, Inc. (PFE) downgraded to Hold by Jefferies
Friday,  Jul 12, 2013  8:25 AM ET

Rating:
Buy PFE
up 16.86 %
Pfizer, Inc. (PFE) rated Overweight by Morgan Stanley
Wednesday,  Jul 10, 2013  10:25 AM ET

Rating:
Sell PFE
down 17.52 %

Rating:
Sell PFE
down 13.71 %
Pfizer, Inc. (PFE) rated Reduce by Sun Trust Rbsn Humphrey
Thursday,  May 30, 2013  8:25 AM ET

Rating:
Hold PFE
Pfizer, Inc. (PFE) downgraded to Neutral by Credit Suisse
Thursday,  Feb 7, 2013  8:25 AM ET

Rating:
Buy PFE
up 123.82 %
Pfizer, Inc. (PFE) rated Buy with price target $31 by UBS
Wednesday,  Jan 30, 2013  11:25 AM ET

Rating:
Buy PFE
up 20.76 %
Pfizer, Inc. (PFE) rated Buy with price target $32 by Argus
Wednesday,  Jan 30, 2013  8:25 AM ET

Your Recent Stocks
SymbolLastChange
PFE 32.89 down  -1.11 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy